PRKCA and multiple sclerosis: association in two independent populations.
Multiple sclerosis (MS) is a chronic disease of the central nervous system responsible for a large portion of neurological disabilities in young adults. Similar to what occurs in numerous complex diseases, both unknown environmental factors and genetic predisposition are required to generate MS. We ascertained a set of 63 Finnish MS families, originating from a high-risk region of the country, to identify a susceptibility gene within the previously established 3.4-Mb region on 17q24. Initial single nucleotide polymorphism (SNP)-based association implicated PRKCA (protein kinase C alpha) gene, and this association was replicated in an independent set of 148 Finnish MS families (p = 0.0004; remaining significant after correction for multiple testing). Further, a dense set of 211 SNPs evenly covering the PRKCA gene and the flanking regions was selected from the dbSNP database and analyzed in two large, independent MS cohorts: in 211 Finnish and 554 Canadian MS families. A multipoint SNP analysis indicated linkage to PRKCA and its telomeric flanking region in both populations, and SNP haplotype and genotype combination analyses revealed an allelic variant of PRKCA, which covers the region between introns 3 and 8, to be over-represented in Finnish MS cases (odds ratio = 1.34, 95% confidence interval 1.07-1.68). A second allelic variant, covering the same region of the PRKCA gene, showed somewhat stronger evidence for association in the Canadian families (odds ratio = 1.64, 95% confidence interval 1.39-1.94). Initial functional relevance for disease predisposition was suggested by the expression analysis: The transcript levels of PRKCA showed correlation with the copy number of the Finnish and Canadian "risk" haplotypes in CD4-negative mononuclear cells of five Finnish multiplex families and in lymphoblast cell lines of 11 Centre d'Etude du Polymorphisme Humain (CEPH) individuals of European origin.
Saarela
Janna
J
Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland. Janna.Saarela@ktl.fi
Kallio
Suvi P
SP
Chen
Daniel
D
Montpetit
Alexandre
A
Jokiaho
Anne
A
Choi
Eva
E
Asselta
Rosanna
R
Bronnikov
Denis
D
Lincoln
Matthew R
MR
Sadovnick
A Dessa
AD
Tienari
Pentti J
PJ
Koivisto
Keijo
K
Palotie
Aarno
A
Ebers
George C
GC
Hudson
Thomas J
TJ
Peltonen
Leena
L
D000328:Adult; D000483:Alleles; D002170:Canada; D005260:Female; D005387:Finland; D008040:Genetic Linkage; D005819:Genetic Markers; D014644:Genetic Variation; D006239:Haplotypes; D006801:Humans; D008297:Male; D008957:Models, Genetic; D009103:Multiple Sclerosis / Q000209:etiology* / Q000235:genetics; D016366:Open Reading Frames; D020641:Polymorphism, Single Nucleotide; D011153:Population / Q000235:genetics; D051571:Protein Kinase C-alpha / Q000235:genetics* / Q000378:metabolism; D017422:Sequence Analysis, DNA
D005819:Genetic Markers; C496628:PRKCA protein, human; D051571:Protein Kinase C-alpha